<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181130041803N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-03</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of provision of information on anxiety before surgery in patients with breast cancer</public_title>
      <acronym></acronym>
      <scientific_title>The effect of provision of information on anxiety before surgery in patients with breast cancer</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-01-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/35587</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Random Rearranged Block Designs Two Blind Quadruple Treatments:
 Thus, the letter A for the intervention group and the letter B for the control group are considered. Then we write all the reciprocal combinations of the letters A, A, B and B, which are 6 different combinations, on the 6 cards, thus:
1. AABB
2. ABBA
3. ABAB
4. BAAB
5. BABA
6. BBAA
Then we select random numbers from digits 1 through 6 (by random number table or patient number one we want to randomly select a card). For example, if the number 2 is selected, the concept is that the first person in the intervention group was the next two in the control group and the fourth in the intervention group, and we continue to do this until the sample size reaches the quotient.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Breast Cancer. Condition 2: Salivary cortisol. Condition 3: Anxiety before surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in the intervention group included all patients aged 18 years before menopause with definite diagnosis of breast cancer who were admitted for unilateral mastectomy for at least 24 hours in the Department of Women's Surgery or Immunomotor Cancer Institute who were randomly assigned to blocks Four have been selected in this group after collecting information about demographic and salivary samples from 3 to 5 cc before being informed. Saliva samples are taken to measure cortisol concentrations between 8:30 and 7:30 in the morning. Brushing and eating and drinking is not allowed for the client for half an hour before taking saliva. Samples are immediately sent to the laboratory and freeze at -20 ° F. Then it is centrifuged at 2500 rpm and ultimately measured by ELISA and using the kit of salivary cortisol. Then, the DASS-21 anxiety inventory questionnaire will be completed by patients with the presence of the researcher. To the intervention group, in order to inform and inform before surgery, the written information includes information on patient health and surgical care and post-operative care, and oral explanations and responses to the questions of the patients are also done by the researcher. The saliva sample is collected again and the DASS-21 questionnaire is completed. Intervention 2: Control group: Patients in the control group included all patients aged 18 before menopause with a diagnosis of breast cancer who were admitted for unilateral mastectomy for at least 24 hours in the gynecologic department of Imam Khomeini Cancer Institute who were randomly assigned to blocks Four have been selected in this group after collecting information about demographic and salivary samples from 3 to 5 cc before being informed. Saliva samples are taken to measure cortisol concentrations between 8:30 and 7:30 in the morning. Brushing and eating and drinking is not allowed for the client for half an hour before taking saliva. Samples are immediately sent to the laboratory and freeze at -20 ° F. Then it is centrifuged at 2500 rpm and ultimately measured by ELISA and using the kit of salivary cortisol. Then, the DASS-21 anxiety inventory questionnaire will be completed by patients with the presence of the researcher. The control group only receives routine pre-surgical training information. Then again, collect the saliva and complete the DASS-21 questionnaire.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The total potential data can be shared after unidentifiable individuals

When:
Get started 6 months after printing results

To whom:
Researchers in academic and scientific institutions

Conditions:
Post-print results will be announced

Where to obtain:
Library of the Faculty of Nursing and Midwifery, Tehran University of Medical Sciences

How to obtain:
Post-print results will be announced

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>sara pakzad karamad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 7751 4933</telephone>
        <email>sarah.pakzad.karamad.1991@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>sara pakzad karamad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>141973317</zip>
        <telephone>+98 21 6691 4368</telephone>
        <email>sarah.pakzad.karamad.1991@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The first surgical experience
Ability to read and write
Mastering in Persian language
There is no familial relationship with other participants in the research
There is no cancer in the family
Not to be a medical staff
Do not have a speech and hearing problem
Dementia and cognitive impairment
At least 24 hours in hospital
No medications that reduce or increase cortisol (such as corticosteroids, anticonvulsants, insulin)
One-way mastectomy candidate is a one-way mastectomy candidate
Definitive diagnosis of breast cancer</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Any severe changes and deterioration in the condition during the study
Any type of offensive treatment during the study
Any patient dissatisfaction during the implementation of the project</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in the intervention group included all patients aged 18 years before menopause with definite diagnosis of breast cancer who were admitted for unilateral mastectomy for at least 24 hours in the Department of Women's Surgery or Immunomotor Cancer Institute who were randomly assigned to blocks Four have been selected in this group after collecting information about demographic and salivary samples from 3 to 5 cc before being informed. Saliva samples are taken to measure cortisol concentrations between 8:30 and 7:30 in the morning. Brushing and eating and drinking is not allowed for the client for half an hour before taking saliva. Samples are immediately sent to the laboratory and freeze at -20 ° F. Then it is centrifuged at 2500 rpm and ultimately measured by ELISA and using the kit of salivary cortisol. Then, the DASS-21 anxiety inventory questionnaire will be completed by patients with the presence of the researcher. To the intervention group, in order to inform and inform before surgery, the written information includes information on patient health and surgical care and post-operative care, and oral explanations and responses to the questions of the patients are also done by the researcher. The saliva sample is collected again and the DASS-21 questionnaire is completed</i_keyword>
      <i_keyword>Control group: Patients in the control group included all patients aged 18 before menopause with a diagnosis of breast cancer who were admitted for unilateral mastectomy for at least 24 hours in the gynecologic department of Imam Khomeini Cancer Institute who were randomly assigned to blocks Four have been selected in this group after collecting information about demographic and salivary samples from 3 to 5 cc before being informed. Saliva samples are taken to measure cortisol concentrations between 8:30 and 7:30 in the morning. Brushing and eating and drinking is not allowed for the client for half an hour before taking saliva. Samples are immediately sent to the laboratory and freeze at -20 ° F. Then it is centrifuged at 2500 rpm and ultimately measured by ELISA and using the kit of salivary cortisol. Then, the DASS-21 anxiety inventory questionnaire will be completed by patients with the presence of the researcher. The control group only receives routine pre-surgical training information. Then again, collect the saliva and complete the DASS-21 questionnaire.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Measuring the salivary cortisol. Timepoint: ۶۷/۵۰۰۰Measure salivary cortisol before the intervention and the morning after the intervention. Method of measurement: Salivary Cortisol Measurement by ELISA Method by Measuring Saline Cortisol Kit.</prim_outcome>
      <prim_outcome>Psychological anxiety score of patients with mastectomy candidates in DASS-21 questionnaire. Timepoint: Measurement of anxiety at the beginning of the study and the day after the interventionپرسشنامه. Method of measurement: Anxiety and Stress Questionnaire DASS-21.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-11-06</approval_date>
        <contact_name>کمیته اخلاق در پژوهش های زیست پزشکی</contact_name>
        <contact_address>Tehran University of Medical Sciences.,Dr Mirkhani St. (Eastern Nusrat).,Tohid Square تهران Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
